Effective home telehealth monitoring of lung disease–COPD and other chronic diseases–has been elusive. An Israeli company with a US office, Deep Breeze, has adapted its hospital-based vibration response imaging (VRI) technology, approved by the FDA in 2007, for home use. It works thru an array of sensors in a vest which records acoustic lung vibrations, then converts the vibrations into images and quantitative parameters representing lung function. This year the second-gen version will start to go through the long FDA review process; Ed. Donna notes that Deep Breeze will be exhibiting at ATA 2011. Israel 21c
UPDATE 28 April 2011: Deep Breeze pre-ATA press release. Heads-up thanks to Boaz Babai.